TICKERNOMICS Sign up
Last Update: 2024-03-28 02:11:10
PROCEPT BioRobotics Corp ( PRCT ) https://www.procept-biorobotics.com
46.41USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
PRCT
68.58%
SPY
32.74%
PRCT
0.00%
SPY
92.93%
PRCT
0.00%
SPY
224.41%
PRCT
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2356.28
2150.40
0.23
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-21.63
20.25
8.39
-8.92
0.00
-21.39
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-72.96
53.77
-78.70
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
-31.05
-32.37
0.00
Other Earnings and Cash Flow Stats:
PROCEPT BioRobotics Corp ( PRCT ) Net Income TTM ($MM) is -106.75
PROCEPT BioRobotics Corp ( PRCT ) Operating Income TTM ($MM) is -101.13
PROCEPT BioRobotics Corp ( PRCT ) Owners' Earnings Annual ($MM) is 0.00
PROCEPT BioRobotics Corp ( PRCT ) Current Price to Owners' Earnings ratio is 0.00
PROCEPT BioRobotics Corp ( PRCT ) EBITDA TTM ($MM) is -96.59
PROCEPT BioRobotics Corp ( PRCT ) EBITDA Margin is -78.70%
Capital Allocation:
PROCEPT BioRobotics Corp ( PRCT ) has paid 0.00 dividends per share and bought back -6.371 million shares in the past 12 months
PROCEPT BioRobotics Corp ( PRCT ) has reduced its debt by 28.107 million USD in the last 12 months
Capital Structure:
PROCEPT BioRobotics Corp ( PRCT ) Interest-bearing Debt ($MM) as of last quarter is 51
PROCEPT BioRobotics Corp ( PRCT ) Annual Working Capital Investments ($MM) are 26
PROCEPT BioRobotics Corp ( PRCT ) Book Value ($MM) as of last quarter is 280
PROCEPT BioRobotics Corp ( PRCT ) Debt/Capital as of last quarter is 18%
Other Balance Sheet Stats:
PROCEPT BioRobotics Corp ( PRCT ) has 257 million in cash on hand as of last quarter
PROCEPT BioRobotics Corp ( PRCT ) has 45 million of liabilities due within 12 months, and long term debt 51 as of last quarter
PROCEPT BioRobotics Corp ( PRCT ) has 50 common shares outstanding as of last quarter
PROCEPT BioRobotics Corp ( PRCT ) has 0 million USD of preferred stock value
Academic Scores:
PROCEPT BioRobotics Corp ( PRCT ) Altman Z-Score is 10.19 as of last quarter
PROCEPT BioRobotics Corp ( PRCT ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
PROCEPT BioRobotics Corp ( PRCT ) largest shareholder is Polar Asset Management Partners owning 463259 shares at 21.50 ($MM) value
Nouri Alaleh(an insider) Sold 441 shares of PROCEPT BioRobotics Corp ( PRCT ) for the amount of $21534.03 on 2024-03-18
4.03% of PROCEPT BioRobotics Corp ( PRCT ) is held by insiders, and 77.06% is held by institutions
PROCEPT BioRobotics Corp ( PRCT ) went public on 2021-09-15
Other PROCEPT BioRobotics Corp ( PRCT ) financial metrics:
FCF:-98.46
Unlevered Free Cash Flow:-126.45
EPS:-1.94
Operating Margin:-72.96
Gross Profit Margin:53.77
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-35.08
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About PROCEPT BioRobotics Corp ( PRCT ) :
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.